Mianserin. An example of balancing benefits and risks in therapy.
D000380:Agranulocytosis / Q000139:chemically induced; D003362:Cost-Benefit Analysis; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use*; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D007700:Kinetics; D008803:Mianserin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*
D003984:Dibenzazepines; D008803:Mianserin